Ursodeoxycholic Acid Market
- 2026 年市場規模
- USD 600 Mn
- 2033 年預估規模
- USD 1,050 Mn
- 年複合成長率 CAGR
- 8.3%
以上數字由 Coherent Market Insights 於本報告中提出，量子訊息原樣引用。
授權報價
| Single User Price | $4,500 USD |
| Enterprise License | $10,000 USD |
完整報告名稱與涵蓋範圍
Ursodeoxycholic Acid Market, By Type (Branded and Generics), By Dosage Form (Tablets, Capsules, and Oral Suspensions), By Strength (150 mg, 250 mg, 300 mg, and 500 mg), By Indication (Primary Biliary Cholangitis (PBC), Gallstone Dissolution, Cholestatic Liver Diseases, Primary Sclerosing Cholangitis (PSC), Intrahepatic Cholestasis of Pregnancy (ICP), Cystic Fibrosis-Associated Liver Disease, and Other Hepatobiliary Disorders), By Age Group (Adult and Pediatric), By Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, and Online Pharmacies), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)
報告摘要
The global ursodeoxycholic acid market is estimated to be valued at USD 600 Mn in 2026 and is expected to reach USD 1,050 Mn by 2033, exhibiting a compound annual growth rate (CAGR) of 8.3% from 2026 to 2033. Ursodeoxycholic Acid (UDCA) is an essential drug used within the global pharmaceutical industry. It is utilized as a naturally occurring bile acid with significant clinical potential within the management of hepatobiliary diseases. Although, initially derived from bear bile, it has been synthesized and established as the primary treatment for primary biliary cholangitis (PBC) and other liver-related illnesses.
The compound works through the reduction of cholesterol absorption, enhancement of the dissolution of cholesterol gallstones, and the provision of hepatoprotective effects through its anti-inflammatory and immunomodulatory properties. The global ursodeoxycholic acid market comprises pharmaceutical products such as tablets, capsules, and injectable solutions, thereby addressing the needs of various patient groups within the fields of hepatology, gastroenterology, and medicine.
The market growth is driven by the increasing prevalence of liver diseases, awareness about the use of bile acid therapy, and increasing applications in the treatment of non-alcoholic fatty liver disease and primary sclerosing cholangitis. The ursodeoxycholic acid market caters to a wide range of stakeholders such as pharmaceutical companies, healthcare organizations, patients, and research institutions, with vast differences in the adoption rates and regulatory requirements. As global healthcare systems focus on managing liver health and the need for effective treatments for long-term liver and bile duct diseases, the ursodeoxycholic acid market is changing. This involves new formulations and a wider range of medical uses.
Market Dynamics
There are numerous factors driving the growth of the global ursodeoxycholic acid market and together they are constantly expanding the demand for this product in healthcare sectors. The major factor behind this expansion is the rising cases of liver-related diseases all over the globe primary biliary cholangitis, non-alcoholic fatty liver disease, cholestatic liver disorders, etc. Clearly, the need for a bile acid therapy that works well is high.
Furthermore, the elderly population prone to hepatobiliary issues is increasing while at the same time, the soaring obesity levels leading to fatty liver disease are greatly increasing the chances for this market. Moreover, technological breakthroughs in pharmaceutical production methods, UDCA manufacture has become not only more efficient but also a higher quality product while going deeper into research of new therapeutic applications, the market that can be catered by UDCA is becoming bigger.
The market however is not without its grievances; one of the notable drawbacks is the high cost of treatment associated with long-term UDCA therapy which may restrict the patients' ability to avail this therapy as well as the adoption of this therapy by healthcare systems especially in the case of emerging economies. On the other hand, generic versions are likely to put pricing pressure on branded products whereas strict drug approvals and good manufacturing practices regulations could lead to difficulties in the operation of market participants. Besides these, lack of enough information on bile acid therapy among general practitioners and patients in some regions acts as a market restraint.
However, despite these challenges, there are tremendous opportunities that arise from the development of healthcare infrastructure in developing markets, government initiatives for the management of liver diseases, and investments in hepatology research. The opportunities that arise from combination therapies that include UDCA with other drugs are lucrative, while the development of telemedicine platforms makes patient monitoring easier.
Key Features of the Study
• This report provides in-depth analysis of the global ursodeoxycholic acid market, and provides market size (USD Million) and compound annual growth rate (CAGR%) for the forecast period (2026–2033), considering 2025 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global ursodeoxycholic acid market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Merck KGaA, Symbiotec Pharmalab Pvt.Ltd, Daewoong Bio Inc., Dipharma Francis S.r.l., ICE S.p.A., Dr.Falk Pharma GmbH, Octavious Pharma Pvt.Ltd., Grindeks AS, Arch Pharmalabs Ltd., and Axplora
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global ursodeoxycholic acid market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global ursodeoxycholic acid market
Market Segmentation
• Type Insights (Revenue, USD Mn, 2021 - 2033)
o Branded
o Generics
• Dosage Form Insights (Revenue, USD Mn, 2021 - 2033)
o Tablets
o Capsules
o Oral Suspensions
• Strength Insights (Revenue, USD Mn, 2021 - 2033)
o 150 mg
o 250 mg
o 300 mg
o 500 mg
• Indication Insights (Revenue, USD Mn, 2021 - 2033)
o Primary Biliary Cholangitis (PBC)
o Gallstone Dissolution
o Cholestatic Liver Diseases
o Primary Sclerosing Cholangitis (PSC)
o Intrahepatic Cholestasis of Pregnancy (ICP)
o Cystic Fibrosis-Associated Liver Disease
o Other Hepatobiliary Disorders
• Age Group Insights (Revenue, USD Mn, 2021 - 2033)
o Adult
o Pediatric
• Distribution Channel Insights (Revenue, USD Mn, 2021 - 2033)
o Hospitals Pharmacies
o Retail Pharmacies
o Online Pharmacies
• Regional Insights (Revenue, USD Mn, 2021 - 2033)
o North America
U.S.
Canada
o Latin America
Brazil
Argentina
Mexico
Rest of Latin America
o Europe
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
o Asia Pacific
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
o Middle East
GCC Countries
Israel
Rest of Middle East
o Africa
South Africa
North Africa
Central Africa
• Key Players Insights
o Merck KGaA
o Symbiotec Pharmalab Pvt.Ltd
o Daewoong Bio Inc
o Dipharma Francis
o ICE S.p.A.
o Falk Pharma GmbH
o Octavious Pharma Pvt.Ltd
o Grindeks AS
o Arch Pharmalabs Ltd
o Axplora
目錄 Table of Contents
Table of Contents
1. Research Objectives and Assumptions
o Research Objectives
o Assumptions
o Abbreviations
2. Market Purview
o Report Description
Market Definition and Scope
o Executive Summary
Global Ursodeoxycholic Acid Market, By Type
Global Ursodeoxycholic Acid Market, By Dosage Form
Global Ursodeoxycholic Acid Market, By Strength
Global Ursodeoxycholic Acid Market, By Indication
Global Ursodeoxycholic Acid Market, By Age Group
Global Ursodeoxycholic Acid Market, By Distribution Channel
Global Ursodeoxycholic Acid Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
o Impact Analysis
o Key Highlights
o Regulatory Scenario
o Product Launches/Approvals
o PEST Analysis
o PORTER’s Analysis
o Market Opportunities
o Regulatory Scenario
o Key Developments
o Industry Trends
4. Global Ursodeoxycholic Acid Market, By Type, 2021-2033, (USD Mn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 - 2033
Segment Trends
o Branded
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Generics
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
5. Global Ursodeoxycholic Acid Market, By Dosage Form, 2021-2033, (USD Mn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 - 2033
Segment Trends
o Tablets
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Capsules
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Oral Suspensions
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
6. Global Ursodeoxycholic Acid Market, By Strength, 2021-2033, (USD Mn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 - 2033
Segment Trends
o 150 mg
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o 250 mg
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o 300 mg
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o 500 mg
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
7. Global Ursodeoxycholic Acid Market, By Indication, 2021-2033, (USD Mn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 - 2033
Segment Trends
o Primary Biliary Cholangitis (PBC)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Gallstone Dissolution
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Cholestatic Liver Diseases
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Primary Sclerosing Cholangitis (PSC)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Intrahepatic Cholestasis of Pregnancy (ICP)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Cystic Fibrosis-Associated Liver Disease
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Other Hepatobiliary Disorders
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
8. Global Ursodeoxycholic Acid Market, By Age Group, 2021-2033, (USD Mn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 - 2033
Segment Trends
o Adult
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Pediatric
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
9. Global Ursodeoxycholic Acid Market, By Distribution Channel, 2021-2033, (USD Mn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 - 2033
Segment Trends
o Hospitals Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Retail Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Online Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
10. Global Ursodeoxycholic Acid Market, By Region, 2021 - 2033, Value (USD Mn)
o Introduction
Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Mn)
Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Mn)
Regional Trends
o North America
Introduction
Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Dosage Form, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Strength, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
o U.S.
o Canada
o Latin America
Introduction
Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Dosage Form, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Strength, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
o Brazil
o Argentina
o Mexico
o Rest of Latin America
o Europe
Introduction
Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Dosage Form, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Strength, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
o Germany
o U.K.
o Spain
o France
o Italy
o Russia
o Rest of Europe
o Asia Pacific
Introduction
Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Dosage Form, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Strength, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
o China
o India
o Japan
o Australia
o South Korea
o ASEAN
o Rest of Asia Pacific
o Middle East
Introduction
Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Dosage Form, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Strength, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
o GCC Countries
o Israel
o Rest of Middle East
o Africa
Introduction
Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Dosage Form, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Strength, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Mn)
o South Africa
o North Africa
o Central Africa
11. Competitive Landscape
o Merck KGaA
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Symbiotec Pharmalab Pvt.Ltd
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Daewoong Bio Inc
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Dipharma Francis
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o ICE S.p.A.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Falk Pharma GmbH
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Octavious Pharma Pvt.Ltd
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Grindeks AS
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Arch Pharmalabs Ltd
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Axplora
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
12. Analyst Recommendations
o Wheel of Fortune
o Analyst View
o Coherent Opportunity Map
13. References and Research Methodology
o References
o Research Methodology
o About us
*Browse 32 market data tables and 28 figures on 'Ursodeoxycholic Acid Market' - Global forecast to 2033
提及公司
同分類最新報告（醫療與生命科學）
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們